135 related articles for article (PubMed ID: 31517734)
21. Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
Vassal G; Terrier-Lacombe MJ; Bissery MC; Vénuat AM; Gyergyay F; Bénard J; Morizet J; Boland I; Ardouin P; Bressac-de-Paillerets B; Gouyette A
Br J Cancer; 1996 Aug; 74(4):537-45. PubMed ID: 8761367
[TBL] [Abstract][Full Text] [Related]
22. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
[TBL] [Abstract][Full Text] [Related]
23. A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma.
Fernandez MC; Krailo MD; Gerbing RR; Matthay KK
Cancer; 2000 Jun; 88(12):2838-44. PubMed ID: 10870069
[TBL] [Abstract][Full Text] [Related]
24. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
[TBL] [Abstract][Full Text] [Related]
25. Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H; Michon J; Plantaz D; Peyroulet MC; Coze C; Frappaz D; Chastagner P; Baranzelli MC; Méchinaud F; Boutard P; Lutz P; Perel Y; Leverger G; de Lumley L; Millot F; Stéphan JL; Margueritte G; Hartmann O
Br J Cancer; 1998 Jun; 77(12):2310-7. PubMed ID: 9649151
[TBL] [Abstract][Full Text] [Related]
26. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient.
Lones MA; Kirov I; Said JW; Shintaku IP; Neudorf S
Bone Marrow Transplant; 2000 Nov; 26(9):1021-4. PubMed ID: 11100284
[TBL] [Abstract][Full Text] [Related]
27. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma.
Mishima Y; Nagasaki E; Terui Y; Irie T; Takahashi S; Ito Y; Oguchi M; Kawabata K; Kamata S; Hatake K
Cancer; 2004 Sep; 101(6):1437-44. PubMed ID: 15368332
[TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
30. [Malignant neuroectodermal tumor of the arm in a 15-year-old girl successfully treated with chemo- and radiotherapy].
Armata J; Grześkowiak-Melanowska J; Dłuzniewska A
Pediatr Pol; 1995 Nov; 70(11):977-9. PubMed ID: 8677166
[TBL] [Abstract][Full Text] [Related]
31. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Valteau-Couanet D; Michon J; Boneu A; Rodary C; Perel Y; Bergeron C; Rubie H; Coze C; Plantaz D; Bernard F; Chastagner P; Bouzy J; Hartmann O
J Clin Oncol; 2005 Jan; 23(3):532-40. PubMed ID: 15659499
[TBL] [Abstract][Full Text] [Related]
32. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
33. Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor.
Emminger W; Gadner H
Pediatr Hematol Oncol; 1992; 9(2):183-5. PubMed ID: 1356004
[No Abstract] [Full Text] [Related]
34. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
[TBL] [Abstract][Full Text] [Related]
35. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
Kushner BH; LaQuaglia MP; Bonilla MA; Lindsley K; Rosenfield N; Yeh S; Eddy J; Gerald WL; Heller G; Cheung NK
J Clin Oncol; 1994 Dec; 12(12):2607-13. PubMed ID: 7527454
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Neuroblastoma with a Novel Delayed Intensification Chemotherapy.
Zhang YT; Chang J; Xu HM; Li YN; Zhong XD; Liu ZL
Indian J Pediatr; 2019 Feb; 86(2):126-131. PubMed ID: 30076520
[TBL] [Abstract][Full Text] [Related]
37. Dose-intensive use of cyclophosphamide in ablation of neuroblastoma.
Kushner BH; O'Reilly RJ; LaQuaglia M; Cheung NK
Cancer; 1990 Sep; 66(6):1095-100. PubMed ID: 2400963
[TBL] [Abstract][Full Text] [Related]
38. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
Kushner BH; Kramer K; LaQuaglia MP; Modak S; Yataghene K; Cheung NK
J Clin Oncol; 2004 Dec; 22(24):4888-92. PubMed ID: 15611504
[TBL] [Abstract][Full Text] [Related]
39. Primitive neuroectodermal tumor of maxilla in an adult.
Shah N; Roychoudhury A; Sarkar C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Dec; 80(6):683-6. PubMed ID: 8680976
[TBL] [Abstract][Full Text] [Related]
40. An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma.
Michon JM; Hartmann O; Bouffet E; Meresse V; Coze C; Rubie H; Bordigoni P; Cattiaux E; Ward N; Bernard JL; Lemerle J; Zucker JM; Philip T
Eur J Cancer; 1998 Jun; 34(7):1063-9. PubMed ID: 9849455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
